Paradise Ultrasound Renal Denervation System
Payments companies reported to CMS as associated with Paradise Ultrasound Renal Denervation System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Paradise Ultrasound Renal Denervation System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Paradise Ultrasound Renal Denervation System
These are the largest totals companies reported as associated with Paradise Ultrasound Renal Denervation System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Bloch | Reno, NV | Internal Medicine | $34,539.07 |
| Aravinda Nanjundappa | Beckley, WV | Interventional Cardiology | $22,058.33 |
| Surabhi Atreja | Sacramento, CA | Interventional Cardiology | $21,191.42 |
| Naomi Fisher | Boston, MA | Endocrinology, Diabetes & Metabolism | $18,410.63 |
| Amir Kaki | Detroit, MI | Interventional Cardiology | $16,092.35 |
| Brian Brown | Spartanburg, SC | Interventional Cardiology | $15,206.63 |
| Jorge Gutierrez | Durham, NC | Interventional Cardiology | $14,163.45 |
| Orestis Pappas | Erie, PA | Interventional Cardiology | $12,521.36 |
| Joseph Garasic | Boston, MA | Interventional Cardiology | $11,496.67 |
| Angela Brown | Saint Louis, MO | Cardiovascular Disease | $11,125.90 |
Prescribed Paradise Ultrasound Renal Denervation System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.